| Product Code: ETC12541769 | Publication Date: Apr 2025 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of liposomal doxorubicin to Brunei in 2024 continued to be dominated by top exporting countries such as Malaysia, Singapore, Ireland, United Kingdom, and Germany. The high concentration levels observed in 2023 further intensified in 2024, indicating a very high degree of market concentration. Despite the negative compound annual growth rate (CAGR) of -12.9% from 2020 to 2024, there was a slightly improved growth rate of -11.63% from 2023 to 2024. These trends suggest a challenging market environment for liposomal doxorubicin imports in Brunei.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Liposomal Doxorubicin Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Liposomal Doxorubicin Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Liposomal Doxorubicin Market - Industry Life Cycle |
3.4 Brunei Liposomal Doxorubicin Market - Porter's Five Forces |
3.5 Brunei Liposomal Doxorubicin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Brunei Liposomal Doxorubicin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Brunei Liposomal Doxorubicin Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Brunei Liposomal Doxorubicin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brunei Liposomal Doxorubicin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Brunei |
4.2.2 Growing awareness about the benefits of liposomal doxorubicin in cancer treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced treatments |
4.3 Market Restraints |
4.3.1 High cost associated with liposomal doxorubicin compared to conventional chemotherapy |
4.3.2 Limited availability of specialized healthcare facilities for administering liposomal doxorubicin |
5 Brunei Liposomal Doxorubicin Market Trends |
6 Brunei Liposomal Doxorubicin Market, By Types |
6.1 Brunei Liposomal Doxorubicin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Doxil, 2021 - 2031F |
6.1.4 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Lipodox, 2021 - 2031F |
6.1.5 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Myocet, 2021 - 2031F |
6.1.6 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Brunei Liposomal Doxorubicin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.3 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.2.4 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.2.5 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Kaposi's Sarcoma, 2021 - 2031F |
6.3 Brunei Liposomal Doxorubicin Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4 Brunei Liposomal Doxorubicin Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Brunei Liposomal Doxorubicin Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Brunei Liposomal Doxorubicin Market Import-Export Trade Statistics |
7.1 Brunei Liposomal Doxorubicin Market Export to Major Countries |
7.2 Brunei Liposomal Doxorubicin Market Imports from Major Countries |
8 Brunei Liposomal Doxorubicin Market Key Performance Indicators |
8.1 Patient survival rates post liposomal doxorubicin treatment |
8.2 Number of clinical trials and research studies involving liposomal doxorubicin in Brunei |
8.3 Adoption rate of liposomal doxorubicin by healthcare providers in Brunei |
9 Brunei Liposomal Doxorubicin Market - Opportunity Assessment |
9.1 Brunei Liposomal Doxorubicin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Brunei Liposomal Doxorubicin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Brunei Liposomal Doxorubicin Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Brunei Liposomal Doxorubicin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brunei Liposomal Doxorubicin Market - Competitive Landscape |
10.1 Brunei Liposomal Doxorubicin Market Revenue Share, By Companies, 2024 |
10.2 Brunei Liposomal Doxorubicin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |